AVITA MEDICAL INC.

1.37%

$1.81

Market Cap $123.4M

Healthcare Biotechnology

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies... AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.More

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting...

Latest Threads

Tag

Subject

AVH

Ann: AVITA Announces First Clinical Publication for Cohealyx

11:21

856

11:21

Last post ThaLuvDocta

856

AVH

Ann: Statement of CDIs on issue - AVH

10:07

176

10:07

Last post

ASX News

176

AVH

Ann: Results of 2025 Annual Meeting of Stockholders

09:50

3.2K

09:50

Last post ThaLuvDocta

3.2K

AVH

New Avita announcement states breakthrough treatment from completed trials

07:56

143

07:56

Last post compint

143

AVH

Ann: Notification of cessation of securities - AVH

05/06/25

207

05/06/25

Last post

ASX News

207

AVH

Ann: 2025 ASM Chairman Script

04/06/25

580

04/06/25

Last post talung66

580

AVH

Ann: 2025 Annual Meeting of Stockholders Presentation

04/06/25

280

04/06/25

Last post

ASX News

280

AVH

Ann: RECELL Honored for Surgical Innovation - 2025 MedTech Awards

04/06/25

771

04/06/25

Last post BD3099

771

See All Discussions

Timeline

Statement of CDIs on issue - AVH
06 Jun 09:47	Share

AVITA Announces First Clinical Publication for Cohealyx
06 Jun 08:21	Share

Notification of cessation of securities - AVH
05 Jun 10:50	Share

Results of 2025 Annual Meeting of Stockholders
05 Jun 09:04	Share

2025 ASM Chairman Script
04 Jun 16:06	Share

2025 Annual Meeting of Stockholders Presentation
04 Jun 16:02	Share

Notification of cessation of securities - AVH
04 Jun 09:50	Share

RECELL Honored for Surgical Innovation - 2025 MedTech Awards
04 Jun 09:40	Share

Notification of Form 8-K Filing
16 May 08:22	Share

Notice under section 708A(5)(e) of the Corporations Act
15 May 13:11	Share

Notification regarding unquoted securities - AVH
15 May 13:09	Share

AVITA Medical Acute Wound Care Showcase 2025 Reminder
13 May 16:03	Share

Financial Results for Quarter Ending 31 March 2025
09 May 08:25	Share

AVITA Medical Q1 2025 Earnings Presentation
09 May 08:25	Share

AVITA Medical Reports Q1 2025 Financial Results
09 May 08:25	Share

Statement of CDIs on issue - AVH
07 May 11:27	Share

Notification regarding unquoted securities - AVH
06 May 11:18	Share

Notification of cessation of securities - AVH
02 May 08:44	Share

AVITA Medical to Host Acute Wound Care Showcase
24 Apr 16:58	Share

Notice of Annual Meeting/Proxy Statement
23 Apr 08:22	Share

AVITA Medical to Announce First Quarter 2025 Results
22 Apr 08:12	Share

AVH to Present Breakthrough Clinical Data at ABA 2025
10 Apr 08:25	Share

Statement of CDIs on issue - AVH
07 Apr 14:45	Share

AVH Launches Cohealyx, Expanding U.S. Market Opportunity
04 Apr 08:20	Share

Notification of cessation of securities - AVH
03 Apr 09:58	Share

Notice under section 708A(5)(e) of the Corporations Act
24 Mar 09:48	Share

Notification regarding unquoted securities - AVH
24 Mar 09:36	Share

Notice under section 708A(5)(e) of the Corporations Act
20 Mar 09:55	Share

Notification regarding unquoted securities - AVH
20 Mar 09:47	Share

AVH Announces New Manufacturing AGMT & Amends Distribution
18 Mar 08:19	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.81		Change -0.025(1.37%)		Mkt cap ! $123.4M

Open	High	Low	Value	Volume
$1.84	$1.84	$1.80	$525.4K	290.0K

Buyers (Bids)

No.	Vol.	Price($)
1	7521	$1.81

Sellers (Offers)

Price($)	Vol.	No.
$1.82	655	1

View Market Depth

No.	Vol.	Price($)
1	7521	1.805
16	53963	1.800
2	11000	1.795
5	16437	1.790
3	16374	1.780

Price($)	Vol.	No.
1.820	655	1
1.890	9999	1
1.900	7597	2
1.910	239	1
1.950	300	1

Last trade - 16.10pm 06/06/2025 (20 minute delay)


Last $1.81		Change -0.025 ( 1.13 %)
Open	High	Low	Volume
$1.81	$1.83	$1.80	40493
Last updated 15.58pm 06/06/2025 ?

AVH (ASX) Chart

AVITA MEDICAL INC.

Latest Threads

Learning from Morocco secrets to 'unlock' Elizabeth Hill silver trove

Timeline

Featured News

Latest Articles

Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin

Avita (ASX:AVH) has announced its development of a 'dermal matrix' – in other words, a kind of next-gen gauze made of a material closer to skin than cotton.

FDA greenlights Avita's RECELL GO skin transplant cell harvesting device

Avita Medical (ASX:AVH) has announced the US FDA has issued a premarket approval for its RECELL GO skin cell harvesting device.

AVITA Medical drops revenue forecast for Q1

AVITA Medical (ASX:AVH) provided an update on its anticipated revenue for Q1 2024 - and has now downgraded its commercial revenue guidance for the quarter

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News